Given global market dynamics, I'm a big fan of investing in pharmaceutical companies right now. The aging western population and growth in developing countries will continue increasing drug demand for the foreseeable future. According to Centers for Medicare & Medicaid Services, prescription drug spending is projected to grow at an average of 6.3% per year through 2025.
What I also like about pharmaceutical stocks is that an investor doesn't have to choose between growth and income. It's possible to invest in a company that is growing faster than the overall market but also consistently returning a significant amount of capital to shareholders.
Attached, I've compiled stocks from the pharma drug, generic drug and major drug manufacturing industry with a low forward P/E. I like some of them, especially ABBVIE, PFIZER and NOVO NORDISK.
What are your favorites?
This article was written by Dividend Yield. If you enjoyed this article, please subscribe to his feed [RSS].
